Physiologically based pharmacokinetic (PBPK) models are increasingly being used to describe and define more meaningful parameters that relate to physiology, anatomy, and biochemistry in the prediction of pharmacokinetic (PK) profiles and tissue concentration–time profiles of the parent drug and metabolites and to provide mechanistic insight into drug dynamics. Physiological data (blood flow rates and tissue volumes), physical data (protein binding and tissue partition coefficients), and biochemical data (Michaelis–Menten parameters for transporters and enzymes,
V
max
/
K
m
) are the information required for building a PBPK model. The whole‐body PBPK model approach is extremely useful to understand sequential metabolism, the kinetics of metabolites, and examine effects of the transporter and enzyme interplay on the blood and target organ exposures of the drug and its metabolites. The application of PBPK models allows one to make predictions of the exposure in target sites, pharmacological activity, or toxicity and the effects of age, pregnancy, disease states, and drug–drug interactions (DDIs). In this chapter, many cases for the application and usefulness of PBPK models are summarized.